NL-OMON36311招募中4 期
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATION - From tacrolimus to everolimus for improvement of the kidney function
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult patients (18 years or older) who have received an ABO-compatible single-organ kidney transplant from a living donor and who are on the immunusuppressive regimen of: tacrolimus, mycophenolate mofetil and prednisolon.
排除标准
- •Patients need to be on immunosuppressive therapy with tacrolimus, prednisolon and mycophenolate mofetil at 3 months after transplantation.
研究者
相似试验
进行中（未招募）
不适用
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATIOKidney TransplantationEUCTR2010-019398-14-NLErasmus Medical Center
尚未招募
不适用
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATION.Kidney transplant recipientsTacrolimusEverolimusNiertransplantatie patiëntenNL-OMON24603Erasmus Medical Center250
已完成
不适用
Renal functional improvement after transcatheter aortic valve implantation in patients with chronic kidney diseasesevere aortic valve stenosis chronic kidney diseaseJPRN-UMIN000038576Tokyo Women's Medical University121
招募中
不适用
Evaluation of renal function before and after catheter ablation of atrial fibrillatioatrial fibrillationJPRN-UMIN000027201Gunma Prefectural Cardiovascular Center300
招募中
不适用
Consideration the changes of renal function for renal cell carcinoma patients, administered the molecular target drugs: axitinib, sunitinib and sorafenibRenal cell carcinomaJPRN-UMIN000019393Dokkyo Medical University, Department of Urology30